DURHAM, NC, USA and Cambridge, UK – Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, and EpiCypher®, the leading provider of ChIC/CUT&RUN technology, today announced a partnership to help researchers generate high-confidence epigenomic insights faster. By combining EpiCypher’s CUTANA™ ChIC/CUT&RUN platform with Abcam’s expertise in antibody development and characterization, the collaboration […]

Improves Antibody Yield by About 10% in the Purification Process TOKYO and KYOTO — FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) and HORIBA, Ltd. (President: Masayuki Adachi) today announced the co-development of a high-sensitivity inline Raman measurement system*1 that enables continuous, real-time monitoring of component concentrations directly from bioreactor and process equipment during cell […]

NEW YORK and WOKING, England — IDBS, a Danaher company and leading provider of cloud software for biopharma, and Alchemi, a leading applied AI company serving the world’s largest pharma and biotech development teams, today announced a partnership connecting AI agents to data captured and contextualized in the IDBS Polar platform across the drug development lifecycle. Preparing regulatory […]

Improves Antibody Yield by About 10% in the Purification Process TOKYO & KYOTO, Japan — FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) and HORIBA, Ltd. (President: Masayuki Adachi) today announced the co-development of a high-sensitivity inline Raman measurement system*1 that enables continuous, real-time monitoring of component concentrations directly from bioreactor and process equipment […]

Collaboration with Leiden University Medical Center (LUMC) will explore application of electronic genome mapping (EGM) in facioscapulohumeral muscular dystrophy (FSHD) Poster presentation today at the European Society of Human Genetics (ESHG) 2026 Annual Meeting demonstrates ability of OhmX™ Platform to detect repeat expansion assays via EGM, optimized with CRISPR/Cas9 PROVIDENCE, R.I. — Nabsys 2.0, LLC (Nabsys), […]

Partnership expands access to next-generation protein quantitation technology across Japan’s biopharmaceutical and life sciences markets BILLERICA, Mass. — Nirrin Technologies, a developer of analytical tools designed to transform bioprocessing workflows, today announced the appointment of S.T. Japan as its exclusive distribution partner for the TALOS™ protein quantitation system in Japan. S.T. Japan, a specialized provider […]

The companies’ integrated Cellario OS™ and Mosaic platforms, already deployed by 5 of the top 10 global pharma companies, eliminate manual workflow handoffs, improve traceability and create the infrastructure foundation for agentic laboratory automation. BEVERLY, Mass. and LONDON — HighRes®, a leading provider of laboratory automation and orchestration software, and Cenevo, the specialist in enabling agentic, […]

GOTHENBURG, Sweden — MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation in life sciences, is showcasing its latest advancements in sequencing, automation and clinical genomics at the European Society of Human Genetics (ESHG) 2026 Conference in Gothenburg, Sweden. At Booth 352, MGI welcomes researchers, clinicians, laboratory […]

The Twist Fast Hyb App joins Twist’s Standard Hyb v2 App on Callisto, giving labs a fully walk-away path to target enrichment, with run-to-run consistency and same-day turnaround BOSTON — Volta Labs, the genomics applications company transforming next-generation sequencing (NGS) sample preparation through automation, today announced the launch of the App for Twist Bioscience’s Fast […]

Hartwig to adopt Ultima Genomics’ UG200 sequencing system to accelerate implementation of whole-genome-based clinical genomics workflows on Solaris 2.0 technology Hartwig and Ultima to continue implementation and validation of ppmSeq, the only decentralizable whole-genome solution commercially available today for monitoring of minimal residual disease (MRD) with low single-digit part-per-million sensitivity AMSTERDAM and FREMONT, Calif. — […]